Ana Maria Pereira Silva

Dr. Ana Maria Pereira Silva

The Institute of Biomedical Sciences Abel Salazar, University of Porto, Porto, Portugal
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2011 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
GPGoncalo Pereira
Goncalo Pereira
Ana Maria Pereira SilvaAna Maria Pereira Silva
Ana Maria Pereira Silva
CDCatia V. Diogo
Catia V. Diogo
FCFilipa Carvalho
Filipa Carvalho
PMPedro Monteiro
Pedro Monteiro
POPaulo Oliveira
Paulo Oliveira
Mitochondria have long been involved in several cellular processes beyond its role in energy production. The importance of this organelle for cardiac tissue homeostasis has been greatly investigated and its impairment can lead to cell death and consequent organ failure. Several compounds have been described in the literature as having direct effects on cardiac mitochondria which can provide a mechanistic explanation for their toxicological or pharmacological effects. The present review describes one classic example of druginduced cardiac mitochondrial toxicity and another case of drug-induced mitochondrial protection. For the former, we present the case of doxorubicin, an anticancer agent whose treatment is associated with a cumulative and dose-dependent cardiomyopathy with a mitochondrial etiology. Following this, we present the case of carvedilol, a β-blocker with intrinsic antioxidant activity, which has been described to protect cardiac mitochondria from oxidative injury. The final part of the review integrates information from the previous chapters, demonstrating how carvedilol can contribute to reduce doxorubicin toxicity on cardiac mitochondria. The two referred examples result in important take-home messages: a) drug-induced cardiac mitochondrial dysfunction is an important contributor for drug-associated organ failure, b) protection of mitochondrial function is involved in the beneficial impact of some clinically-used drugs and c) a more accurate prediction of toxic vs. beneficial effects should be an important component of drug development by the pharmaceutical industry.

1 September 2014 in The Journal of Steroid Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
Ana C. MoreiraAna C. Moreira
Ana C. Moreira
Ana Maria Pereira SilvaAna Maria Pereira Silva
Ana Maria Pereira Silva
MSMaria S. Santos
Maria S. Santos
VSVilma Sardão
Vilma Sardão

1 June 2013 in Toxicology Letters
Verified
Journal Article
Closed access
Teresa Cunha-OliveiraTeresa Cunha-Oliveira
Teresa Cunha-Oliveira
Lisbeth SilvaLisbeth Silva
Lisbeth Silva
Ana Maria Pereira SilvaAna Maria Pereira Silva
Ana Maria Pereira Silva
AMAntónio J. Moreno
António J. Moreno
COCatarina R. Oliveira
Catarina R. Oliveira
MSMaria S. Santos
Maria S. Santos